Seeking Alpha

Seeking Alpha Portfolio App for iPad

Jason Napodano

Jason Napodano picture

Profile

Send Message

View as an RSS Feed

View Jason Napodano's Articles BY TICKER:

LabStyle Innovations - Glucose Monitoring For The Mobile Age
on Wed, May 15 • AAPL, ABT, ECTE • 12 Comments
A Look At Neurocrine's VMAT-2 Inhibitor As Phase IIb Data Nears
on Fri, May 10 • ABBV, NBIX • 1 Comment
Review Of Depomed's First Quarter 2013 Results
on Thu, May 9 • MRK, JNJ, SNTS • 3 Comments
Cipher Pharma Continues To Deliver
on Mon, May 6 • CPHMF.PK • 2 Comments
Why I Think InVivo Is Under-Valued
on Mon, Apr 29 • NVIV.OB • 22 Comments
Amarantus' LymPro Could Be A Game-Changer For Alzheimer's Diagnosis
on Wed, Apr 17 • FRX, LLY, PFE • 16 Comments
FDA Agrees To Expedited Path To NDA For Pimavanserin
on Fri, Apr 12 • ACAD • 5 Comments
Omni Bio Pharmaceutical's Better Solution For Treating An Orphan Disease, And More
on Thu, Apr 11 • OMBP.OB • 1 Comment
Aastrom's Shocking News And Future Potential
on Wed, Mar 27 • ASTM • 7 Comments
Checking In On Organovo
on Wed, Mar 20 • PFE, UTHR, ONVO.PK • 24 Comments
What You Need To Know About Aastrom Bio
on Wed, Mar 20 • ASTM • 4 Comments
Tonix Readies For Pivotal Fibromyalgia Program
on Wed, Mar 13 • TNXP.OB • 5 Comments
Valuing Amarantus - Where Financial Reality Meets Scientific Hope
on Mon, Mar 11 • ATHX, CUR, AMBS.OB • 12 Comments
A Deal For Pozen's PA Could Send Shares Soaring
on Wed, Mar 6 • AZN, GSK, POZN • 7 Comments
OxySure To Piggyback On AED Boom
on Tue, Feb 19 • OXYS.OB • 1 Comment
Scientific Literature Suggests Amarantus' MANF Has Big Potential
on Wed, Feb 13 • AMGN, AMBS.OB • 21 Comments
OxySure Systems' Emergency Oxygen Device Ready For Takeoff
on Tue, Jan 15 • OXYS.OB • 8 Comments
Transformation Underway At Cipher
on Fri, Nov 30, 2012 • CPHMF.PK, RBXZF.PK • 1 Comment
Tonix: A Small Biotech With The Potentially Huge Key To The Fibromyalgia Puzzle
on Thu, Oct 25, 2012 • FRX, JNJ, LLY • 19 Comments
A Bare Bones Valuation On Zalicus: Over 40% Upside Potential
on Wed, Oct 10, 2012 • COV, SNY, ZLCS • 41 Comments
Looking At DepoMed's Serada For Hot Flashes
on Wed, Oct 3, 2012 • DEPO • Comment!
Neurocrine's VMAT-2 Enters Phase IIb
on Tue, Oct 2, 2012 • ABT, NBIX • Comment!
Reckitt's Decision Opens The Door For Titan Pharma And BioDelivery Sciences
on Wed, Sep 26, 2012 • TTNP.OB, BDSI, RBGPF.PK • 8 Comments
Buy Pozen Ahead Of Key Medical Meetings
on Mon, Sep 24, 2012 • POZN • 12 Comments
Titan Enters Exclusive Talks To Partner Probuphine
on Fri, Sep 14, 2012 • TTNP.OB • 18 Comments
Time To Buy DARA Bio
on Fri, Sep 14, 2012 • DARA • 44 Comments
Buy Durect As Visibility On Remoxy Improves
on Tue, Sep 11, 2012 • PFE, PTIE, DRRX • 5 Comments
What Lilly's Failure Means For Addex
on Wed, Aug 29, 2012 • ADDXF.PK, JNJ, LLY • 1 Comment
Partnership For Addex Could Send Shares Higher
on Thu, Aug 23, 2012 • ADDXF.PK • 1 Comment
An In-Depth Look At Organovo
on Mon, Aug 20, 2012 • ONVO.PK • 13 Comments
GAIN Act Should Benefit Antibiotic Makers
on Wed, Jun 27, 2012 • CBST, CEMP, OPTR • 3 Comments
CMS Coverage Big Positive For Cytomedix
on Thu, May 10, 2012 • CMXI.OB • 8 Comments